Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

High Efficiency Water Treatment Company Desalitech Wins $11 Million Investment

GlobeNewswire December 2, 2014

Microscopy Market Worth $5,756.0 Million by 2019

PR Newswire December 2, 2014

Research and Markets: 4th International Conference and Exhibition on Pathology - July 13-15, 2015 at New Orleans, USA

Business Wire December 2, 2014

Adaptive Biotechnologies and Collaborators Present 13 Studies Demonstrating Clinical Relevance of Immunosequencing at 56th Annual Meeting of the American Society for Hematology

PR Newswire December 2, 2014

Sumo Logic Surpasses All Goals and Hires Industry Veteran Ramin Sayar as CEO to Lead Rapid Growth Phase

Marketwired December 2, 2014

NMS Labs Selects RapidHIT® Platform to Deliver DNA Results in Record Time

Business Wire December 2, 2014

Arizona Oncology Receives Recognition for Quality Cancer Care from Largest Oncology Society in U.S.

Business Wire December 2, 2014

HealthStar PR Announces Appointment of Healthcare PR Veteran David Bashaw as Executive Vice President

Business Wire December 2, 2014

New Data Strengthens Correlation between Biomarker and Cancer Immunotherapeutic Imprime PGG

Business Wire December 2, 2014

Paragonix Technologies Inc., Announces Clearance of Two 510(k) Premarket Notifications by the US Food and Drug Administration

Business Wire December 2, 2014

European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypoparathyroidism

Business Wire December 2, 2014

United States Patent Awarded for Computerized DNA Mixture Analysis

Business Wire December 2, 2014

Research and Markets: Asia-Pacific Ureteroscopes Market Outlook to 2020: Key players covered include Olympus, Hoya, Richard Wolf and KARL STORZ GmbH & Co

Business Wire December 2, 2014

Endonovo Therapeutics Receives Final Commissioned Report Recommendations Regarding FDA Regulatory Pathway for Urinary Incontinence Treatment

Marketwired December 2, 2014

Space Coast Credit Union Joins the More Than 50 Financial Institutions That Have Selected DNA Since Fiserv Acquired Open Solutions

Business Wire December 2, 2014

Rexel USA Collaborates with Q CELLS to Begin Distribution of Solar Modules

Business Wire December 2, 2014

Invitae Receives Accreditation for Its Laboratory from the College of American Pathologists

Business Wire December 2, 2014

Draft Sequence of a Diploid A-Genome Cotton Generated & Released to Public by Texas Tech University, Bayer CropScience, and the National Center for Genome Resources

PR Newswire December 2, 2014

$100 Million Fundraising Initiative - Strong Against Cancer - Launches With Goal of Curing Childhood Cancer

PR Newswire December 2, 2014

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 Size, Share - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

PR Newswire December 2, 2014